Search tips
Search criteria 


Logo of jpnSubmit a ManuscriptEmail AlertsAbout JPNJournal of Psychiatry and Neuroscience
J Psychiatry Neurosci. 1995 January; 20(1): 11–19.
PMCID: PMC1188653

Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.


The uptake of [3H]5-HT and the density (Bmax) as well as affinity (Kd) of 5-HT uptake sites labelled with [3H]paroxetine and of 5-HT2 receptors labelled by [3H]LSD were determined in platelets from 25 medication-free patients with major depression and 20 normal controls. The density (Bmax) of 5-HT2 receptors was found to be significantly increased (by 52%) in platelets from depressed patients, particularly females. No changes were found in the affinity (Kd) of 5-HT2 receptors and in 5-HT uptake or [3H]paroxetine binding parameters. Density of 5-HT2 receptors positively correlated with that of [3H]paroxetine sites in control but not in depressed subjects. No correlation was found between the HAMD scores and Bmax of [3H]LSD binding. The results suggest that upregulation of platelet 5-HT2 receptors is a useful biological marker in major depression, particularly in females.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Arora RC, Meltzer HY. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sci. 1989;44(11):725–734. [PubMed]
  • Arora RC, Meltzer HY. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry. 1989 Jun;146(6):730–736. [PubMed]
  • Arora RC, Meltzer HY. A modified assay method for determining serotonin uptake in human platelets. Clin Chim Acta. 1981 May 5;112(2):225–233. [PubMed]
  • Arora RC, Wunnicke V, Meltzer HY. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets. Biol Psychiatry. 1985 Jan;20(1):116–119. [PubMed]
  • Asberg M, Träskman L, Thorén P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry. 1976 Oct;33(10):1193–1197. [PubMed]
  • Bech P, Eplov L, Gastpar M, Gentsch C, Mendlewicz J, Plenge P, Rielaert C, Mellerup ET. WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study. Pharmacopsychiatry. 1988 May;21(3):147–150. [PubMed]
  • Biegon A, Weizman A, Karp L, Ram A, Tiano S, Wolff M. Serotonin 5-HT2 receptor binding on blood platelets--a peripheral marker for depression? Life Sci. 1987 Nov 30;41(22):2485–2492. [PubMed]
  • Biegon A, Essar N, Israeli M, Elizur A, Bruch S, Bar-Nathan AA. Serotonin 5-HT2 receptor binding on blood platelets as a state dependent marker in major affective disorder. Psychopharmacology (Berl) 1990;102(1):73–75. [PubMed]
  • Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science. 1980 Jul 11;209(4453):303–305. [PubMed]
  • Brusov OS, Beliaev BS, Katasonov AB, Zlobina GP, Factor MI, Lideman RR. Does platelet serotonin receptor supersensitivity accompany endogenous depression? Biol Psychiatry. 1989 Feb 15;25(4):375–381. [PubMed]
  • Cowen PJ, Charig EM, Fraser S, Elliott JM. Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment. J Affect Disord. 1987 Jul-Aug;13(1):45–50. [PubMed]
  • de Chaffoy de Courcelles D, Leysen JE, De Clerck F, Van Belle H, Janssen PA. Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. J Biol Chem. 1985 Jun 25;260(12):7603–7608. [PubMed]
  • D'haenen H, De Waele M, Leysen JE. Platelet 3H-paroxetine binding in depressed patients. Psychiatry Res. 1988 Oct;26(1):11–17. [PubMed]
  • Faludi G, Magyar I, Tekes K, Tothfalusi L, Magyar K. Measurement of 3H-serotonin uptake in blood platelets in major depressive episodes. Biol Psychiatry. 1988 Apr 15;23(8):833–836. [PubMed]
  • Geaney DP, Schächter M, Elliot JM, Grahame-Smith DG. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes. Eur J Pharmacol. 1984 Jan 13;97(1-2):87–93. [PubMed]
  • Gross-Isseroff R, Israeli M, Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Arch Gen Psychiatry. 1989 Mar;46(3):237–241. [PubMed]
  • Habert E, Graham D, Tahraoui L, Claustre Y, Langer SZ. Characterization of [3H]paroxetine binding to rat cortical membranes. Eur J Pharmacol. 1985 Nov 26;118(1-2):107–114. [PubMed]
  • Healy D, Theodorou AE, Whitehouse AM, Lawrence KM, White W, Wilton-Cox H, Kerry SM, Horton RW, Paykel ES. 3H-imipramine binding to previously frozen platelet membranes from depressed patients, before and after treatment. Br J Psychiatry. 1990 Aug;157:208–215. [PubMed]
  • Heninger GR, Charney DS, Sternberg DE. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch Gen Psychiatry. 1984 Apr;41(4):398–402. [PubMed]
  • Hrdina PD, Lapierre YD, Horn ER, Bakish D. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):619–623. [PubMed]
  • Hrdina PD, Foy B, Hepner A, Summers RJ. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter. J Pharmacol Exp Ther. 1990 Jan;252(1):410–418. [PubMed]
  • Hrdina PD, Demeter E, Vu TB, Sótónyi P, Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res. 1993 Jun 18;614(1-2):37–44. [PubMed]
  • Hrdina PD, Vu TB. Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse. 1993 Aug;14(4):324–331. [PubMed]
  • Jeanningros R, Gronier B, Azorin JM, Tissot R. Platelet [3H]-imipramine binding according to DSM-III subtypes of depression. Neuropsychobiology. 1989;22(1):33–40. [PubMed]
  • Kellar KJ, Cascio CS, Butler JA, Kurtzke RN. Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur J Pharmacol. 1981 Feb 19;69(4):515–518. [PubMed]
  • Klimek V, Zak-Knapik J, Mackowiak M. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain. J Psychiatry Neurosci. 1994 Jan;19(1):63–67. [PMC free article] [PubMed]
  • Lesch KP, Wolozin BL, Murphy DL, Reiderer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem. 1993 Jun;60(6):2319–2322. [PubMed]
  • Mann JJ, McBride PA, Brown RP, Linnoila M, Leon AC, DeMeo M, Mieczkowski T, Myers JE, Stanley M. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry. 1992 Jun;49(6):442–446. [PubMed]
  • Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978 Jun 15;87(1):206–210. [PubMed]
  • McBride PA, Mann JJ, Polley MJ, Wiley AJ, Sweeney JA. Assessment of binding indices and physiological responsiveness of the 5-HT2 receptor on human platelets. Life Sci. 1987 May 4;40(18):1799–1809. [PubMed]
  • Mellerup ET, Plenge P, Rosenberg R. 3H-imipramine binding sites in platelets from psychiatric patients. Psychiatry Res. 1982 Oct;7(2):221–227. [PubMed]
  • Mellerup ET, Plenge P, Engelstoft M. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes. Eur J Pharmacol. 1983 Dec 23;96(3-4):303–309. [PubMed]
  • Meltzer HY, Umberkoman-Wiita B, Robertson A, Tricou BJ, Lowy M, Perline R. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania. Arch Gen Psychiatry. 1984 Apr;41(4):366–374. [PubMed]
  • Meltzer HY, Arora RC, Baber R, Tricou BJ. Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiatry. 1981 Dec;38(12):1322–1326. [PubMed]
  • Nemeroff CB, Knight DL, Krishnan RR, Slotkin TA, Bissette G, Melville ML, Blazer DG. Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. Arch Gen Psychiatry. 1988 Oct;45(10):919–923. [PubMed]
  • Nemeroff CB. The presynaptic serotonin uptake site in depression. Clin Neuropharmacol. 1992;15 (Suppl 1 Pt A):347A–348A. [PubMed]
  • Pandey GN, Pandey SC, Janicak PG, Marks RC, Davis JM. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry. 1990 Aug 1;28(3):215–222. [PubMed]
  • Peroutka SJ, Snyder SH. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science. 1980 Oct 3;210(4465):88–90. [PubMed]
  • Perry EK, Marshall EF, Blessed G, Tomlinson BE, Perry RH. Decreased imipramine binding in the brains of patients with depressive illness. Br J Psychiatry. 1983 Feb;142:188–192. [PubMed]
  • Stanley M, Mann JJ. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet. 1983 Jan 29;1(8318):214–216. [PubMed]
  • Steckler T, Rüggeberg-Schmidt K, Müller-Oerlinghausen B. Human platelet 5-HT2 receptor binding sites re-evaluated: a criticism of current techniques [corrected]. J Neural Transm Gen Sect. 1993;92(1):11–24. [PubMed]
  • Tuomisto J, Tukiainen E. Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients. Nature. 1976 Aug 12;262(5569):596–598. [PubMed]
  • Wirz-Justice A. Platelet research in psychiatry. Experientia. 1988 Feb 15;44(2):145–152. [PubMed]
  • Yates M, Leake A, Candy JM, Fairbairn AF, McKeith IG, Ferrier IN. 5HT2 receptor changes in major depression. Biol Psychiatry. 1990 Mar 1;27(5):489–496. [PubMed]
  • Young SN, Smith SE, Pihl RO, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berl) 1985;87(2):173–177. [PubMed]

Articles from Journal of Psychiatry & Neuroscience : JPN are provided here courtesy of Canadian Medical Association